Recul clinique - Les Laboratoires TEOXANE

CLINICAL APPRAISAL

 

 

Teoxane IMCAS




SCIENTIFIC INFORMATION / CLINICAL APPRAISAL

Clinical Appraisal

If any side-effects persist longer than one week after the injection, the doctor is encouraged to declare them to their distributor using the form provided. Vital information is then reported to study product traceability and patient history:

Injection date
Date side-effects appeared
Type of side-effects
Treatment prescribed for the patient
Volume injected
Batch number
Description of the patient's medical and cosmetic history
Doctor's opinion on what may be responsible for the side-effects.

The form must be filled in with as much detail as possible outlining the patient's case. The form is processed very quickly after receipt. The doctor is contacted rapidly for details on the patient's case and to supply answers to any questions they may have.

Objective data covering Teoxane's six years of experience is as follows:

Over 1 500 000 syringes injected by May 2010*.
 Outstanding tolerance: 1 < 15 000 reported cases of side-effects, all temporary and local to the site of injection.


The importance of product design and formulas to provide high quality products:
The physical properties of hyaluronic acid gels depend on the molecular weight, concentration and level of cross-linking. These chemical changes do not alter the biocompatibility of hyaluronic acid.

Origin:

Bacterial fermentation (Streptococcus strain): non-pathogenic for humans.

Properties:
 Ubiquitous
 Biocompatible, non-immunogenic.
100% non-animal origin: non-allergenic, no allergy test required before injection.
 Absorbable product.
 Biodegradable product, with progressive absorption by the skin and complete absorption by water and CO2.
Can absorb up to 1000 times its weight in water. High hydrating capacity.
 Visco-elastic: maintains the skin's elasticity. The physical properties of hyaluronic acid gels depend on the molecular weight, concentration and level of cross-linking. Cross-linked hyaluronic acid forms a dense, interlocking mesh.
Stable after injection.
 Cross-linking.
 Purification of cross-linking agent (BDDE).
 Concentration.
 Viscosity.


Teoxane's key assets are its skill and expertise in the supply of high-quality products.

 


  

Laboratoires TEOXANE © - Création de Site Internet: SOFRACS.com - Référencement: Web Alliance